Evaheart, Inc.
Biotechnology ResearchTexas, United States11-50 Employees
Evaheart, Inc. is a biotechnology research company focused on developing left ventricular assist devices (LVADs) for patients with severe heart failure. Based in the Texas Medical Center area of Houston, the company aims to gain regulatory approvals and commercialize its EVAHEART®2 LVAS for North American markets and expansion into Europe, supported by an FDA-approved IDE and a multicenter clinical trial in the United States. The organization positions itself in cardiovascular device research and development, targeting clinicians and patients requiring durable circulatory support. Its work encompasses long-term durability testing, regulatory clearance in Japan, and ongoing clinical studies such as the North American BTT trial, with recent device innovations including a miniaturized pump and an inflow cannula. The company has shown activity in industry conferences and has engaged with major transplant and cardiovascular communities, reflecting its role in advancing LVAD technology for the indicated patient population.
1-888-653-2347 
support@leadiq.com 
